natgillin/translations-raw huggingface dataset:
Before injection, Benepali single-use pre-filled pens should be allowed to reach room temperature (approximately 30 minutes).
Pred injiciranjem je treba počakati, da se napolnjen injekcijski peresnik zdravila Benepali za enkratno uporabo segreje na sobno temperaturo (približno 30 minut).
Before injection, Enbrel single-use pre-filled pens should be allowed to reach room temperature (approximately 15 to 30 minutes).
Pred injiciranjem je treba napolnjene injekcijske peresnike zdravila Enbrel za enkratno uporabo segreti na sobno temperaturo (počakati približno 15 do 30 minut).
Before injection, Enbrel single-use pre-filled syringe should be allowed to reach room temperature (approximately 15 to 30 minutes).
Pred injiciranjem je treba napolnjeno injekcijsko brizgo zdravila Enbrel za enkratno uporabo segreti na sobno temperaturo (počakati približno 15 do 30 minut).
Before injection‚ Kepivance may be allowed to reach room temperature for a maximum of 1 hour but should be protected from light.
Pred injiciranjem lahko zdravilo Kepivance največ eno uro pustite, da doseže sobno temperaturo, vendar ga morate zaščititi pred svetlobo.
Before inserting the needle, use soap and water to clean your hands and the skin where the needle is inserted to avoid any infection at the infusion site.
Preden vstavite iglo, si z milom in vodo umijte roke ter tisti predel kože, v katerega boste zabodli iglo, da boste preprečili okužbo na mestu infundiranja.
Before insertion into the pen, Insuman Basal must be kept at room temperature for 1 to 2 hours and then resuspended to check the contents.
Pred vstavitvijo v injekcijski peresnik mora biti Insuman Basal 1 do 2 uri na sobni temperaturi, potem pa ga je treba za preverjanje vsebine ponovno suspendirati.
Before insertion of the cartridge into the reusable pen OptiClik, the cartridge must be stored at room temperature for 1 to 2 hours.
Preden vložek vstavite v injekcijski peresnik za večkratno uporabo OptiClik, naj bo 1 do 2 uri na sobni temperaturi.
Before insertion of the cartridge into the reusable pen, the cartridge must be stored at room temperature for 1 to 2 hours.
Preden vložek vstavite v injekcijski peresnik, naj bo 1 do 2 uri na sobni temperaturi.
Before insertion of the cartridge into the reusable pen, the cartridge must be stored at room temperature for 1 to 2 hours.
Preden vstavite vložek v injekcijski peresnik za večkratno uporabo, ga morate pustiti na sobni temperaturi 1 do 2 uri.
Before it is used, the powder in the vial which contains tilmanocept is mixed with another medicine called sodium pertechnetate to make a substance called technetium (99mTc) tilmanocept.
Pred uporabo se prašek v viali, ki vsebuje tilmanocept, zmeša z drugim zdravilom, imenovanim natrijev pertehnetat, s čimer se pridobi snov, imenovana tehnecijev (99mTc) tilmanocept.
Before mixing a dose of Norvir, collect the items shown in Figure 1.
Pred mešanjem odmerka zdravila Norvir pripravite vse, kar je prikazano na sliki 1. kozarec pitne vode, formule za dojenčke ali čokoladnega mleka,
Before mixing the two components, the emulsion (adjuvant) and suspension (antigen) should be brought to room temperature (allow a minimum of 15 minutes).
Preden obe komponenti zmešate skupaj, morate emulzijo (adjuvans) in suspenzijo (antigen) vsaj 15 minut pustiti na sobni temperaturi.
Before mixing with the solvent, the powder is a light yellow compact crystalline cake.
Pred mešanjem z vehiklom je prašek svetlo rumen kompakten kristalni skupek.
Before NexoBrid application, a dressing soaked with an antibacterial solution will be applied for 2 hours.
Pred nanosom zdravila NexoBrid vam bodo na rano za 2 uri položili oblogo, namočeno v antibakterijsko raztopino.
Before opening and within its shelf life, the medicinal product may be removed from the refrigerator, without being refrigerated again, for up to 3 months at or below 25°C. The product must be discarded if it has not been used after 3 months.
Pred odprtjem in v času roka uporabnosti se lahko zdravilo vzame iz hladilnika in se shranjuje zunaj njega do 3 mesece, pri temperaturi do 25 °C. Če se ne uporabi, je treba zdravilo po 3 mesecih zavreči.
Before opening and within its shelf life, the medicinal product may be removed from the refrigerator, without being refrigerated again, for up to 3 months at or below 25°C. The product must be discarded if it has not been used after 3 months.
Pred odprtjem in v času roka uporabnosti se lahko zdravilo vzame iz hladilnika in se shranjuje zunaj njega do tri mesece pri temperaturi do 25 °C. Če se zdravilo po treh mesecih ne uporabi, ga je treba zavreči.
Before opening and within its shelf life, you may remove this medicine from the refrigerator, without being refrigerated again, for up to 3 months.
Pred odprtjem in v času roka uporabnosti se lahko zdravilo shranjuje do 3 mesece, brez ponovnega shranjevanja v hladilniku.
Before opening store in a refrigerator (2°C-8°C).
Pred odprtjem hranite v hladilniku (2 °C - 8 °C).
Before opening: 3 years.
Pred odprtjem: 3 leta.
Before opening: NovoMix 30 FlexPen that is not being used must be stored in the refrigerator at 2C to 8C, away from the cooling element.
Pred odprtjem: zdravilo NovoMix 30 FlexPen, ki ga ne uporabljate, shranjujte v hladilniku pri temperaturi 2 °C – 8 °C in ne blizu hladilnega elementa.
Before opening: NovoMix 30 Penfill that is not being used must be stored in the refrigerator at 2C to 8C, away from the cooling element.
Pred odprtjem: zdravilo NovoMix 30 Penfill, ki ga ne uporabljate, shranjujte v hladilniku pri temperaturi 2 °C – 8 °C in ne blizu hladilnega elementa.
Before opening: NovoMix 50 FlexPen that is not being used must be stored in the refrigerator at 2°C to 8°C, away from the cooling element.
Pred odprtjem: zdravilo NovoMix 50 FlexPen, ki ga ne uporabljate, shranjujte v hladilniku pri temperaturi 2 °C – 8 °C in ne blizu hladilnega elementa.
Before opening: NovoMix 50 Penfill that is not being used must be stored in the refrigerator at 2°C to 8°C, away from the cooling element.
Pred odprtjem: zdravilo NovoMix 50 Penfill, ki ga ne uporabljate, shranjujte v hladilniku pri temperaturi 2 °C – 8 °C in ne blizu hladilnega elementa.
Before opening: NovoMix 70 FlexPen that is not being used must be stored in the refrigerator at 2°C to 8°C, away from the cooling element.
Pred odprtjem: zdravilo NovoMix 70 FlexPen, ki ga ne uporabljate, shranjujte v hladilniku pri temperaturi 2 °C – 8 °C in ne blizu hladilnega elementa.
Before opening: NovoMix 70 Penfill that is not being used must be stored in the refrigerator at 2°C to 8°C, away from the cooling element.
Pred odprtjem: zdravilo NovoMix 70 Penfill, ki ga ne uporabljate, shranjujte v hladilniku pri temperaturi 2 °C – 8 °C in ne blizu hladilnega elementa.
Before opening: Store in a refrigerator (2°C – 8°C).
Pred odprtjem: shranjujte v hladilniku (2 °C – 8 °C).
Before opening: Store in a refrigerator (2C to 8C)
Pred odprtjem: shranjujte v hladilniku (2 °C – 8 °C).
Before opening: Store in a refrigerator (2C – 8C).
Pred odprtjem: shranjujte v hladilniku (2 C – 8 C).
Before opening: Store in a refrigerator at 2°C to 8°C. Do not freeze.
Pred odprtjem: shranjujte v hladilniku pri temperaturi 2 °C - 8 °C. Ne zamrzujte.
BEFORE PEDEA IS ADMINISTERED TO YOUR BABY
KAJ MORATE VEDETI, PREDEN BO VAŠ OTROK PREJEL ZDRAVILO PEDEA
Before Pedea is administered to your baby
Kaj morate vedeti, preden bo vaš otrok dobil zdravilo Pedea
Before preparing the Enbrel solution, Enbrel may be stored outside of the refrigerator at temperatures up to a maximum of 25C for a single period of up to four weeks; after which, it should not be refrigerated again.
Pred pripravo raztopine zdravila Enbrel lahko zdravilo Enbrel shranjujete izven hladilnika pri temperaturi do največ 25 °C za enkratno obdobje do štirih tednov, po katerem se ga ne sme več ohladiti.
Before re-suspension the cells are settled to the bottom of the container forming an off-white layer and the excipient is a clear colourless liquid.
Pred resuspenzijo se celice nahajajo na dnu vsebnika in oblikujejo belkasto plast, pomožna snov pa je prozorna brezbarvna tekočina.
Before receiving Aclasta treatment, tell your doctor, pharmacist or nurse if
Preden prejmete zdravilo Aclasta, povejte zdravniku, farmacevtu ali medicinski sestri, če:
Before receiving Blincyto, patients should be given medicines to avoid reactions to the infusion or fever.
Preden bolniki prejmejo zdravilo Blincyto, morajo prejeti zdravila za preprečevanje reakcij na infuzijo ali povišane telesne temperature.
Before receiving Busilvex, you will be medicated with
Preden boste prejeli Busilvex, boste prejeli:
Before receiving Busulfan Fresenius Kabi, you will be medicated with
Preden boste prejeli zdravilo Busulfan Fresenius Kabi, boste prejeli še:
Before receiving Jevtana infusions, patients should first be given anti-allergic medicines to reduce the risk of allergic reactions and anti-emetic medicines to prevent vomiting.
Pred infundiranjem zdravila Jevtana morajo bolniki najprej prejeti protialergijska zdravila, ki zmanjšajo tveganje za alergijske reakcije, in antiemetična zdravila, ki preprečujejo bruhanje.
BEFORE receiving the vaccine
PREDEN prejmete cepivo
Before receiving treatment, tell your doctor/nurse (health care professional) if you have any problems with your mouth or teeth.
Preden dobite zdravilo, morate zdravniku ali medicinski sestri (zdravstvenemu delavcu) povedati, če imate kakšne težave v ustih ali z zobmi.
Before receiving Vistide, the patient’s kidneys must be checked, as the medicine must not be given to patients with kidney disease.
Pred začetkom jemanja zdravila Vistide je treba preveriti delovanje ledvic bolnika, saj bolniki z ledvičnimi obolenji zdravila ne smejo jemati.
Before receiving Zoledronic Acid Hospira, tell your doctor, pharmacist or nurse if
Preden prejmete zdravilo Zoledronska kislina Hospira, povejte zdravniku, farmacevtu ali medicinski sestri, če:
Before receiving Zoledronic acid Teva Pharma treatment, tell your doctor, pharmacist or nurse if
Preden prejmete zdravilo Zoledronska kislina Teva Pharma, povejte zdravniku, farmacevtu ali medicinski sestri, če:
Before reconstitution and dilution:
Pred rekonstitucijo in redčenjem:
Before reconstitution, the powder is a white to off-white-compact, powder.
Pred pripravo je prašek bel do skoraj bel kompakten prašek.
Before reconstitution, visually check the lyophilised powder for any unusual defects e.g. cracking, melted, or a glassy appearance.
Pred rekonstitucijo vizualno preverite liofilizirani prašek in se prepričajte, da ni nenavadnih okvar, npr. da ni razpok, da prašek ni staljen ali da ni videti steklasto.
Before reconstitution, visually check the lyophilised powder for any unusual defects, e.g. cracking, melting or glassy appearance.
Pred rekonstitucijo vizualno preverite liofilizirani prašek in se prepričajte, da ni nenavadnih okvar, npr. da ni razpok, da prašek ni staljen ali da ni videti steklasto.
Before removing the needle from the vial, check the syringe for air bubbles that reduce the amount of Humalog Mix50 in it.
Preden izvlečete iglo iz viale, preverite, ali so v injekcijski brizgi zračni mehurčki, ki zmanjšajo količino zdravila Humalog Mix50 v njej.
Before starting CellCept treatment, women of child bearing potential should have a pregnancy test in order to exclude unintended exposure of the embryo to mycophenolate.
Pred začetkom zdravljenja z zdravilom CellCept morajo bolnice v rodni dobi opraviti test nosečnosti, da izključimo nenamerno izpostavljenost zarodka mikofenolatu.
Before starting CellCept treatment, women of child bearing potential should have a pregnancy test in order to exclude unintended exposure of the embryo to mycophenolate.
Pred začetkom zdravljenja z zdravilom CellCept morajo bolnice v rodni dobi opraviti test nosečnosti, da izključimo nenamerno izpostavljenostzarodka mikofenolatu.
Before starting Mycophenolate mofetil Teva treatment, women of child bearing potential should have a pregnancy test in order to exclude unintended exposure of the embryo to mycophenolate.
Pred začetkom zdravljenja z zdravilom Mofetilmikofenolat Teva morajo bolnice v rodni dobi opraviti test nosečnosti, da izključimo nenamerno izpostavljenost zarodka mikofenolatu.
Before starting Myfenax treatment, women of child bearing potential should have a pregnancy test in order to exclude unintended exposure of the embryo to mycophenolate.
Pred začetkom zdravljenja z zdravilom Myfenax morajo bolnice v rodni dobi opraviti test nosečnosti, da izključimo nenamerno izpostavljenost zarodka mikofenolatu.
Before starting reconstitution you will need the following:
Preden začnete rekonstitucijo morate pripraviti naslednje:
Before starting taking Pravafenix, you should be on a diet to lower your cholesterol.
Pred začetkom jemanja zdravila Pravafenix morate biti na dieti za zniževanje holesterola.
Before starting the preparation, please read these instructions the whole way through first: Give yourself the injection at the same time each day.
Preden začnete s pripravo, najprej v celoti preberite ta navodila: Zdravilo si injicirajte vsak dan ob istem času.
Before starting the treatment your doctor will determine the amount of HER2 in your tumour.
Pred začetkom zdravljenja bo vaš zdravnik določil izraženost HER2 v vašem tumorju.
Before starting the treatment, it is mandatory:
Pred začetkom zdravljenja je nujno:
Before starting the treatment, you should ask your doctor if you are able to become pregnant, even if you think this is unlikely.
Pred začetkom zdravljenja morate vprašati svojega zdravnika, ali lahko zanosite, tudi če mislite, da to ni verjetno.
Before starting the treatment, you should ask your doctor if you are able to become pregnant, even if you think this is unlikely.
Pred začetkom zdravljenja morate vprašati zdravnika, ali je možno, da bi lahko zanosili, tudi če mislite, da to ni verjetno.
Before starting to use this medicine, please read these instructions the whole way through first.
Preden začnete uporabljati to zdravilo, najprej v celoti preberite ta navodila.
Before starting to use this medicine, tell your doctor if you: have ever had ovarian hyperstimulation syndrome OHSS
Preden začnete uporabljati to zdravilo, morate zdravnika obvestiti: če ste kdaj imeli sindrom hiperstimulacije jajčnikov (OHSS),
Before starting to use this medicine, tell your doctor if you: have ever had ovarian hyperstimulation syndrome OHSS.
Pred začetkom uporabe zdravila, zdravniku povejte: če ste imeli kadar koli v preteklosti sindrom hiperstimulacije jajčnikov (OHSS),
Before starting to use your pre-filled pen, please read these instructions the whole way through first.
Preden začnete uporabljati napolnjen injekcijski peresnik, najprej v celoti preberite ta navodila.
Before starting treatment a test must be carried out to make sure that the patient’s tumours have the BRAF V600 mutation.
Pred začetkom zdravljenja je treba narediti test, ki potrdi mutacijo BRAF V600 v tumorskih celicah bolnika.
Before starting treatment for metastatic cancer of the large intestine your doctor will test your cancer cells if they contain the normal (wild-type) or mutant form of RAS.
Pred začetkom zdravljenja metastatskega raka debelega črevesa bo zdravnik testiral vaše rakave celice, ali vsebujejo običajni (nemutirani) ali mutirani tip RAS.
Before starting treatment with abacavir, all patients should have a test to find out if they have a gene called ‘HLA-B (type 5701)’.
Pred začetkom zdravljenja z abakavirjem je treba pri vsakem bolniku opraviti test, s katerim zdravnik ugotovi, ali ima bolnik gen, imenovan HLA-B (tip 5701).
Before starting treatment with Agenerase, please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Preden se pričnete zdraviti z zdravilom Agenerase, obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katero koli zdravilo, tudi če ste ga dobili brez recepta.
Before starting treatment with Benepali, all patients must be evaluated for both active and inactive (‘latent’) tuberculosis.
Pred začetkom zdravljenja z zdravilom Benepali je treba vse bolnike pregledati tako glede aktivne kot tudi glede neaktivne ('latentne') tuberkuloze.
Before starting treatment with Cerdelga, a test should be carried out to find out how rapidly the medicine is broken down in the patients’ bodies (i.e. to determine if they are poor, intermediate, or extensive metabolisers).
Pred začetkom zdravljenja z zdravilom Cerdelga je treba opraviti test, da bi ugotovili, kako hitro bolnikovo telo razgradi zdravilo (tj. da bi določili, ali bolnik spada med slabe, vmesne ali hitre presnavljalce).
Before starting treatment with Enbrel, all patients must be evaluated for both active and inactive (‘latent’) tuberculosis.
Pred začetkom zdravljenja z zdravilom Enbrel je treba vse bolnike pregledati tako glede aktivne kot tudi glede neaktivne ('latentne') tuberkuloze.
Before starting treatment with Flixabi, all patients must be evaluated for both active and inactive (‘latent’) tuberculosis.
Pred začetkom zdravljenja z zdravilom Flixabi morate vse bolnike pregledati in preiskati, da ugotovite morebitno aktivno ali neaktivno (latentno) tuberkulozo.
Before starting treatment with Inflectra, all patients must be evaluated for both active and inactive (‘latent’) tuberculosis.
Pred začetkom zdravljenja z zdravilom Inflectra morate vse bolnike pregledati in preiskati, da ugotovite morebitno aktivno ali neaktivno (latentno) tuberkulozo.
Before starting treatment with Instanyl, the patient’s long-term pain should be well controlled by opioid pain killers and they should have no more than four episodes of breakthrough pain a day.
Pred začetkom zdravljenja z zdravilom Instanyl mora biti dolgotrajna bolečina bolnika primerno uravnana z opioidnimi protibolečinskimi zdravili, bolniki pa ne smejo imeti več kot štiri epizode prebijajoče bolečine na dan.
Before starting treatment with Olysio, patients should have a blood test to check what type of hepatitis C virus they are infected with, as Olysio is known to be less effective if the virus has a mutation (a change in the genetic material of the virus) called Q80K.
Pred začetkom zdravljenja z zdravilom Olysio je treba pri bolnikih opraviti preiskavo krvi, da se preveri, s katero vrsto virusa hepatitisa C so okuženi, saj je zdravilo Olysio dokazano manj učinkovito, če je prisotna mutacija virusa (sprememba genskega materiala virusa), imenovana Q80K.
Before starting treatment with Pravafenix, the doctor should first investigate all possible causes of the patient’s abnormal cholesterol and triglycerides levels and place the patient on a suitable diet.
Pred začetkom zdravljenja z zdravilom Pravafenix mora zdravnik najprej proučiti vse možne vzroke za bolnikove nenormalne ravni holesterola in trigliceridov ter bolniku predpisati ustrezno dieto.
Before starting treatment with Remicade, all patients must be evaluated for both active and inactive (‘latent’) tuberculosis.
Pred začetkom zdravljenja z zdravilom Remicade, morate vse bolnike pregledati in preiskati, da ugotovite morebitno aktivno ali neaktivno (latentno) tuberkulozo.
Before starting treatment with Remsima, all patients must be evaluated for both active and inactive (‘latent’) tuberculosis.
Pred začetkom zdravljenja z zdravilom Remsima morate vse bolnike pregledati in preiskati, da ugotovite morebitno aktivno ali neaktivno (latentno) tuberkulozo.
Before starting treatment with Repatha, secondary causes of excess cholesterol and abnormal fat levels in blood should be excluded.
Pred začetkom zdravljenja z zdravilom Repatha je treba izključiti sekundarne vzroke čezmerne ravni holesterola in nenormalnih ravni maščob v krvi.
Before starting treatment with Simponi, all patients must be evaluated for both active and inactive (‘latent’) tuberculosis.
Pred začetkom zdravljenja z zdravilom Simponi je treba pri vseh bolnikih oceniti, ali imajo morda aktivno oziroma neaktivno (‘latentno’) tuberkulozo.
Before starting treatment with the veterinary medicinal product, it is important that Addison’s disease has been definitively diagnosed.
Pred začetkom zdravljenja z zdravilom za uporabo v veterini je pomembna zanesljiva diagnoza Addisonove bolezni.
Before starting treatment with Translarna, patients will have a blood test done to confirm that their disease is due to a nonsense mutation and that they are therefore suitable for treatment with Translarna.
Pred začetkom zdravljenja z zdravilom Translarna bodo pri bolnikih opravili preiskavo krvi, s katero bodo ugotovili, ali je njihova bolezen posledica nesmiselne mutacije in so torej primerni za zdravljenje z zdravilom Translarna.
Before starting treatment with Triumeq, all patients should have a test to find out if they have a gene called ‘HLA-B (type 5701)’.
Pred začetkom zdravljenja z zdravilom Triumeq je treba pri vseh bolnikih opraviti preiskavo, s katero se ugotovi, ali imajo gen, imenovan „HLA-B (tip 5701)“.
Before starting treatment you should confirm you are not pregnant and are using effective contraception, as advised by your doctor.
Pred začetkom zdravljenja je treba potrditi, da niste noseči in da uporabljate učinkovito kontracepcijo po navodilih zdravnika.
Before starting treatment, all patients should be evaluated for active and inactive (“ latent”) tuberculosis, as per local recommendations.
Pred začetkom zdravljenja je treba vse bolnike oceniti glede aktivne in neaktivne ("latentne") tuberkuloze v skladu z lokalnimi priporočili.
Before starting treatment, doctors must have confirmation that their patients have the T790M mutation.
Pred začetkom zdravljenja morajo zdravniki imeti potrditev, da imajo bolniki mutacijo T790M.
Before starting treatment, tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Obvestite svojega zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali boste morda jemali katero koli zdravilo.
Before starting treatment, tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Obvestite svojega zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
Before starting treatment, the couple's infertility should be assessed as appropriate.
Pred začetkom zdravljenja je treba ustrezno raziskati neplodnost para.
Before starting treatment, the couple’s infertility should be assessed as appropriate and putative contraindications for pregnancy evaluated.
Pred začetkom zdravljenja se mora primerno oceniti neplodnost para ter ovrednotiti domnevne kontraindikacije za nosečnost.
Before starting treatment, the couple’s infertility should be assessed as appropriate.
Pred začetkom zdravljenja je treba pri paru oceniti, ali je njuna neplodnost sploh primerna za tovrstno zdravljenje.
Before starting treatment, you must tell your doctor or nurse if you are pregnant or breast-feeding, or if you think you may be pregnant or are planning to have a baby.
Pred začetkom zdravljenja morate svojemu zdravniku ali medicinski sestri povedati, če ste noseči ali dojite, menite, da bi lahko bili noseči ali načrtujete zanositev.
Before starting treatment, your child’s doctor may order blood tests to assess your child’s kidney function.
Pred začetkom zdravljenja bo njegov zdravnik morda naredil krvne preiskave, da bo ocenil delovanje otrokovih ledvic.
Before starting treatment, your child’s doctor will have taken blood samples to test the resistance of your child’s HIV.
Otrokov zdravnik bo pred začetkom zdravljenja naročil vzorce krvi za preizkus odpornosti virusa HIV, s katerim je vaš otrok okužen.
Before starting, the hands should be washed.
Preden začnete je pomembno, da si umijete roke.
Before stopping Lucentis treatment
Preden prekinete zdravljenje z zdravilom Lucentis
Before stopping Zoledronic Acid Hospira therapy
Preden se prenehate zdraviti z zdravilom Zoledronska kislina Hospira
Before stopping Zoledronic acid Teva Generics therapy
Preden prenehate prejemati zdravilo Zoledronska kislina Teva Generics
Before stopping Zoledronic acid Teva Pharma therapy
Preden prenehate prejemati zdravilo Zoledronska kislina Teva Pharma